Anna Pluciennik
- Thomas Jefferson University · Biochemistry (NIH department code)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
FY2026 NIH rank #17,757
- R01 Holder
- Early Career
- Diverse Portfolio
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 14087628Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Biochemistry
NIH Funding · FY2026
Linked Award Amount
$1.1M
Full award amounts, FY2026
Award Records
3
Records listing this PI
Award-Linked Rank
#17,757
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Anna Pluciennik as a PI. Multi-PI records show the full award amount for context.
- 2R56NS118082-06R56Contact PIMolecular mechanisms of triplet repeat instability in Huntington's diseaseThomas Jefferson University · Biochemistry (NIH department code)$539.1Kaward amount
- 5R01GM144553-04R01Contact PICrosstalk between DNA repair pathways in repeat instabilityThomas Jefferson University · Biochemistry (NIH department code)$312Kaward amount
- 1R35GM164179-01R35Contact PIMolecular systems that modulate nucleic acid repeat instabilitiesThomas Jefferson University · Biochemistry (NIH department code)$247Kaward amount
Award organization
Organizations that administered FY2026 awards listing Anna Pluciennik as a PI.
FY2026 award administered by Thomas Jefferson University (PA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardThomas Jefferson University
- 2024$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025R01 Grant Holder
- 2026$2M Cumulative Funding